Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1997-12-16
Jarvis, William R.A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514654, A61K 3155, A61K 31135
Patent
active
056985495
ABSTRACT:
The instant invention discloses a method of treating hyperactive voiding associated with excessive nerve growth factor production and nerve growth in patients by administering a Ca.sup.++ channel blocker. The Ca.sup.++ channel blockers verapamil and diltiazem can be administered systemically to treat hyperactive voiding, such as is associated with benign prostatic hyperplasia and interstitial cystitis.
REFERENCES:
patent: 5252337 (1993-10-01), Powell
patent: 5354765 (1994-10-01), Pang et al.
Isselbacher, K.J. et al. Harrison's Principles of Internal Medicine, New York: McGraw-Hill, 1985, p. 1353.
Lodish, H et al. Molecular Cell Biology. New York: Scientific American Books, 1986.
Thomas, C.L. Taber's Cyclopedic Medical Dictonary F.A. Davis Co., 1985, p. 1123.
Chodak, G.W., et al. "Increased levels of Fibroblast Growth. Factor-like Activity in Urine from Patients with Bladder or Kidney Cancer." Cancer Research 48:2083-2088, 1988.
Morrison, R.S. "Fibroblast Growth Factors: Potential Neutrophic Agents in the Central Nervous System." Journal of Neuorscience Research 17:99-101, 1987.
"Nerve Growth Factor in the Urinary Bladder of the Adult Regulates Neuronal Form and Function", W.D Steers et al, Journal for Clinical Investigations, vol. 88, Nov. 1991, pp. 1709-1715.
"Nerve Growth Factor Responsiveness of Cultured Major Pelvic Ganglion Neurons from the Adult Rat", Jeremy B. Tuttle et al, Brain Research, 588 (1992) 29-40.
Calcium Channel Antagonists Prevent Urinary Bladder Growth and Neuroplasticity Following Mechanical Stress, William D. Steers et al, American Journal of Physiology, 1994, pp. 20-26.
Steers William D.
Tuttle Jeremy B.
Jarvis William R.A.
Parker Sheldon H.
UVA Patent Foundation
LandOfFree
Method of treating hyperactive voiding with calcium channel bloc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hyperactive voiding with calcium channel bloc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperactive voiding with calcium channel bloc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206302